Intracoronary infusion of bone marrow-derived mononuclear cells contributes to longstanding improvements of left ventricular performance and remodelling after acute myocardial infarction: A meta-analysis

Heart Lung and Circulation

Volumn 21, Issue 11, 2012, Pages 725-733

  Ye, Zhong ^a   Zhang, Bi Li ^a   Zhao, Xian Xian ^a   Qin, Yong Wen ^a   Wu, Hong ^a   Cao, Jiang ^a   Zhang, Jian Liang ^a   Hu, Jian Qiang ^a   Zheng, Xing ^a   Xu, Rong Liang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; Bone marrow derived mononuclear cells; Long term; Meta analysis; Randomised controlled trials

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; BONE MARROW; BONE MARROW DERIVED MONONUCLEAR CELL; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL THERAPY; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE PERFORMANCE; HEART PERFORMANCE; HEART VENTRICLE REMODELING; HUMAN; META ANALYSIS; MONONUCLEAR CELL; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT RESPONSE;

ANIMALS; BONE MARROW CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 84868672762     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2012.06.024     Document Type: Article

References (35)

1. Beitnes J.O., Lunde K., Brinchmann J.E., Aakhus S. Stem cells for cardiac repair in acute myocardial infarction. Expert Rev Cardiovasc Ther 2011, 9:1015-1025.
2. Abdel-Latif A., Bolli R., Tleyjeh I.M., Montori V.M., Perin E.C., Hornung C.A., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007, 167:989-997.
3. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364:141-148.
4. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006, 113:1287-1294.
5. Meyer G.P., Wollert K.C., Lotz J., Pirr J., Rager U., Lippolt P., et al. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 2009, 30:2978-2984.
6. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006, 355:1199-1209.
7. Beitnes J.O., Hopp E., Lunde K., Solheim S., Arnesen H., Brinchmann J.E., et al. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Heart 2009, 95:1983-1989.
8. Assmus B., Rolf A., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., et al. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 2010, 3:89-96.
9. Yousef M., Schannwell C.M., Kostering M., Zeus T., Brehm M., Strauer B.E. The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol 2009, 53:2262-2269.
10. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12.
11. Ioannidis J.P., Patsopoulos N.A., Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ 2007, 335:914-916.
12. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
13. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
14. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700.
15. Beitnes J.O., Gjesdal O., Lunde K., Solheim S., Edvardsen T., Arnesen H., et al. Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study. Eur J Echocardiogr 2011, 12:98-106.
16. Cao F., Sun D., Li C., Narsinh K., Zhao L., Li X., et al. Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. Eur Heart J 2009, 30:1986-1994.
17. Dill T., Schachinger V., Rolf A., Mollmann S., Thiele H., Tillmanns H., et al. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Am Heart J 2009, 157:541-547.
18. Janssens S., Bogaert J., Dubois C., Van Cleemput J., Theunissen K., Kalantzis M., et al. Long-term safety and efficacy of autologous bone marrow-derived stemcell transfer after acute myocardial infarction. Circulation 2006, 114:515.
19. Kaminek M., Meluzin J., Panovsky R., Metelkova I., Budikova M., Richter M. Long-term results of intracoronary bone marrow cell transplantation: the potential of gated sestamibi SPECT/FDG PET imaging to select patients with maximum benefit from cell therapy. Clin Nucl Med 2010, 35:780-787.
20. Lunde K., Solheim S., Forfang K., Arnesen H., Brinch L., Bjornerheim R., et al. Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up. J Am Coll Cardiol 2008, 51:674-676.
21. Meluzin J., Janousek S., Mayer J., Groch L., Hornacek I., Hlinomaz O., et al. Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. Int J Cardiol 2008, 128:185-192.
22. Piepoli M.F., Vallisa D., Arbasi M., Cavanna L., Cerri L., Mori M., et al. Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). Eur J Heart Fail 2010, 12:172-180.
23. Yao K., Huang R., Sun A., Qian J., Liu X., Ge L., et al. Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction. Eur J Heart Fail 2009, 11:691-698.
24. Grajek S., Popiel M., Gil L., Breborowicz P., Lesiak M., Czepczynski R., et al. Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation. Eur Heart J 2010, 31:691-702.
25. Zhang S.N., Sun A.J., Ge J.B., Yao K., Huang Z.Y., Wang K.Q., et al. Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials. Int J Cardiol 2009, 136:178-185.
26. Touchstone D.A., Beller G.A., Nygaard T.W., Tedesco C., Kaul S. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a tomographic assessment using two-dimensional echocardiography. J Am Coll Cardiol 1989, 13:1506-1513.
27. Marino P., Zanolla L., Zardini P. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial. J Am Coll Cardiol 1989, 14:1149-1158.
28. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81(4):1161-1172.
29. Zhang C., Sun A., Zhang S., Yao K., Wu C., Fu M., et al. Efficacy and safety of intracoronary autologous bone marrow-derived cell transplantation in patients with acute myocardial infarction: insights from randomized controlled trials with 12 or more months follow-up. Clin Cardiol 2010, 33:353-360.
30. Marenzi G., Moltrasio M., Assanelli E., Lauri G., Marana I., Grazi M., et al. Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J 2007, 153:755-762.
31. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006, 27:2775-2783.
32. Heggunje P.S., Harjai K.J., Stone G.W., Mehta R.H., Marsalese D.L., Boura J.A., et al. Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004, 44:1400-1407.
33. Nian M., Lee P., Khaper N., Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004, 94:1543-1553.
34. Vandervelde S., van Luyn M.J., Tio R.A., Harmsen M.C. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol 2005, 39:363-376.
35. Bartunek J., Wijns W., Heyndrickx G.R., Vanderheyden M. Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction. Nat Clin Pract Cardiovasc Med 2006, 3(Suppl. 1):S52-S56.